$NHHS
NorthStar Healthcare Income, Inc. Stock $nhhs

$nhhs Overview Financials Valuation SEC Filings Company Website

2014 Q2 Form 10-Q Financial Statement

#000150370714000040 Filed on May 15, 2014

Income Statement

Concept	2014 Q2	2014 Q1	2013 Q1
Revenue	$5.817M	$4.447M	$0.00
YoY Change	14815.38%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$892.0K	$699.0K	$0.00
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$800.0K	$611.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net	$2.730M	$3.846M	$6.088K
YoY Change	17940.2%	63081.64%
Pretax Income	-$249.0K	-$3.438M
YoY Change	-1407.36%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$546.0K	-$3.438M	-$6.088K
YoY Change	-2966.74%	56371.75%
Net Earnings / Revenue	-9.39%	-77.31%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding	26.72M shares	17.45M shares	259.4K shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q2	2014 Q1	2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$80.57M	$75.54M	$2.247M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$359.8M	$246.3M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities	$66.32M	$67.36M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings	-$14.96M	-$9.844M
YoY Change
Common Stock	$307.3M	$187.7M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$292.4M	$177.8M
YoY Change
Total Liabilities & Shareholders Equity	$359.8M	$246.3M
YoY Change

Cashflow Statement

Concept	2014 Q2	2014 Q1	2013 Q1
OPERATING ACTIVITIES
Net Income	-$546.0K	-$3.438M	-$6.088K
YoY Change	-2966.74%	56371.75%
Depreciation, Depletion And Amortization	$892.0K	$699.0K	$0.00
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities		-$1.046M	$0.00
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		-$89.59M	$45.00K
YoY Change		-199177.78%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	303583	USD
CY2014Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	2273916	USD
CY2013Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	947094	USD
CY2014Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	1568147	USD
CY2014Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	187466980	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	97055758	USD
CY2014Q1	us-gaap	Advance Payments By Borrowers For Taxes And Insurance AdvancePaymentsByBorrowersForTaxesAndInsurance	2979812	USD
CY2013Q4	us-gaap	Advance Payments By Borrowers For Taxes And Insurance AdvancePaymentsByBorrowersForTaxesAndInsurance	1794905	USD
CY2013Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4551	USD
CY2014Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	124262	USD
CY2013Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
CY2014Q1	us-gaap	Asset Management Costs AssetManagementCosts	2165521	USD
CY2014Q1	us-gaap	Assets Assets	246289385	USD
CY2013Q4	us-gaap	Assets Assets	115839130	USD
CY2014Q1	us-gaap	Business Combination Acquisition Of Less Than100 Percent Noncontrolling Interest Fair Value BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue	1123884	USD
CY2014Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1680378	USD
CY2014Q1	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	84791225.000	USD
CY2014Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	141177832	USD
CY2014Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Buildings BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings	125043297	USD
CY2014Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Financial Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities	59813425	USD
CY2014Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Land BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand	12015000	USD
CY2014Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	61376880	USD
CY2014Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther	1563455	USD
CY2014Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets	4119535	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45537255	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	75541566	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	202007	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2247014	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	2045007	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	30004311	USD
CY2014Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.17
CY2013Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.00
CY2014Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2014Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21193752	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10985230	shares
CY2014Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21193752	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10985230	shares
CY2014Q1	us-gaap	Common Stock Value CommonStockValue	211937	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	109852	USD
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6083	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3409665	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-3437546	USD
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-6088	USD
CY2014Q1	us-gaap	Cost Of Real Estate Revenue CostOfRealEstateRevenue	1872825	USD
CY2014Q1	us-gaap	Costs And Expenses CostsAndExpenses	7884844	USD
CY2013Q1	us-gaap	Costs And Expenses CostsAndExpenses	6088	USD
CY2014Q1	us-gaap	Costs Of Real Estate Services And Land Sales CostsOfRealEstateServicesAndLandSales	1872825	USD
CY2013Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	18282328	USD
CY2014Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	59735294	USD
CY2013Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	18282328	USD
CY2014Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	59735294	USD
CY2014Q1	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	2656280	USD
CY2013Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	1127845	USD
CY2014Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	699431	USD
CY2013Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	0	USD
CY2014Q1	us-gaap	Dividends Common Stock DividendsCommonStock	1094736	USD
CY2013	us-gaap	Dividends Common Stock DividendsCommonStock	1311886	USD
CY2014Q1	us-gaap	Dividends Common Stock DividendsCommonStock	2562082	USD
CY2014Q1	us-gaap	Dividends Common Stock DividendsCommonStock	691917	USD
CY2014Q1	us-gaap	Dividends Common Stock DividendsCommonStock	775429	USD
CY2014Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	497536	USD
CY2014Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	356437	USD
CY2014Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1169495	USD
CY2014Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	315522	USD
CY2014Q1	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	1392587	USD
CY2014Q1	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	376395	USD
CY2014Q1	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	418992	USD
CY2014Q1	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	597200	USD
CY2013Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	557288	USD
CY2014Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	1094736	USD
CY2013Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	0	USD
CY2014Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	1144663	USD
CY2013Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	1141379	USD
CY2013Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
CY2014Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.22
CY2014Q1	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	3429147	USD
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6088	USD
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	856144	USD
CY2014Q1	us-gaap	Health Care Organization Resident Service Revenue HealthCareOrganizationResidentServiceRevenue	2932224	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1970333	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	0	USD
CY2014Q1	us-gaap	Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance	266129	USD
CY2013Q1	us-gaap	Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance	0	USD
CY2013Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	1537	USD
CY2014Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-574544	USD
CY2013Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	USD
CY2014Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	262052	USD
CY2014Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-129471	USD
CY2013Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	0	USD
CY2013Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	0	USD
CY2014Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	114999	USD
CY2013Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2014Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-399360	USD
CY2014Q1	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	1998781	USD
CY2013Q1	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	0	USD
CY2013Q1	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	0	USD
CY2014Q1	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	111795	USD
CY2014Q1	us-gaap	Interest Expense InterestExpense	610545	USD
CY2013Q1	us-gaap	Interest Income Operating InterestIncomeOperating	0	USD
CY2014Q1	us-gaap	Interest Income Operating InterestIncomeOperating	483282	USD
CY2014Q1	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	121710571	USD
CY2014Q1	us-gaap	Land Land	12015000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	22343233	USD
CY2014Q1	us-gaap	Liabilities Liabilities	67362700	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	115839130	USD
CY2014Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	246289385	USD
CY2014Q1	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	100000000.0	USD
CY2014Q1	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	100000000	USD
CY2014Q1	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	200000000	USD
CY2013Q4	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	25000000.0	USD
CY2014Q1	us-gaap	Long Term Debt LongTermDebt	59735294	USD
CY2014Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	38788884	USD
CY2014Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	143955	USD
CY2014Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	18359987	USD
CY2014Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1805285	USD
CY2014Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	438413	USD
CY2014Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	198770	USD
CY2013Q4	us-gaap	Minority Interest MinorityInterest	202437	USD
CY2014Q1	us-gaap	Minority Interest MinorityInterest	1091665	USD
CY2014Q1	us-gaap	Minority Interest Ownership Percentage By Parent MinorityInterestOwnershipPercentageByParent	0.999
CY2014Q1	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	25887000	USD
CY2013Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	11250000	USD
CY2013Q4	us-gaap	Mortgage Loans On Real Estate Face Amount Of Mortgages MortgageLoansOnRealEstateFaceAmountOfMortgages	11250000	USD
CY2014Q1	us-gaap	Mortgage Loans On Real Estate Interest Rate MortgageLoansOnRealEstateInterestRate	1
CY2012	us-gaap	Mortgage Loans On Real Estate Interest Rate MortgageLoansOnRealEstateInterestRate	1
CY2013	us-gaap	Mortgage Loans On Real Estate Number Of Loans MortgageLoansOnRealEstateNumberOfLoans	1	unit
CY2014Q1	us-gaap	Mortgage Loans On Real Estate Number Of Loans MortgageLoansOnRealEstateNumberOfLoans	2	unit
CY2014Q1	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Business and Organization</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">NorthStar Healthcare Income, Inc. (the “Company”) was formed in October 2010 as a Maryland corporation. The Company was formed primarily to acquire, originate and asset manage a diversified portfolio of equity, debt and securities investments in healthcare real estate, with a focus on the mid-acuity senior housing sector, which the Company defines as assisted living, memory care, skilled nursing and independent living facilities that may have an emphasis on private pay patients. The Company may also acquire and originate equity and debt investments in facilities that may rely on public pay patients and other healthcare property types, including medical office buildings and rehabilitation facilities. In addition, the Company may acquire healthcare-related securities. The Company elected to qualify as a real estate investment trust (“REIT”) beginning with the taxable year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2013</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is externally managed by NorthStar Healthcare Income Advisor, LLC (the “Advisor”) and has </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">no</font><font style="font-family:inherit;font-size:10pt;"> employees. The Advisor uses the investment professionals of NorthStar Realty Finance Corp. (the “Sponsor”) to manage the business. The Advisor is currently a subsidiary of the Sponsor. The Sponsor is a diversified commercial real estate investment and asset management company publicly traded on the New York Stock Exchange (the “NYSE”) and was formed in October 2003.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 10, 2013, the Sponsor announced that its board of directors unanimously approved a plan to spin-off its asset management business into a separate publicly-traded company, NorthStar Asset Management Group Inc. (“NSAM”) in the form of a tax-free distribution. On February 5, 2014, NSAM filed a registration statement on Form 10 with the Securities and Exchange Commission (the “SEC”) to register shares of NSAM’s common stock. The spin-off is expected to be completed in the second quarter of 2014 and the Sponsor expects shares of NSAM common stock to be listed on the NYSE. Following the completion of the spin-off of NSAM, the Advisor will be a subsidiary of NSAM. The Company expects this transaction to have no impact on its operations.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Substantially all business is conducted through NorthStar Healthcare Income Operating Partnership, LP (the “Operating Partnership”). The Company is the sole general partner of the Operating Partnership. The initial limited partners of the Operating Partnership are the Advisor and NorthStar Healthcare Income OP Holdings, LLC (the “Special Unit Holder”). The Advisor invested </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1,000</font><font style="font-family:inherit;font-size:10pt;"> in the Operating Partnership in exchange for common units and the Special Unit Holder invested </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1,000</font><font style="font-family:inherit;font-size:10pt;"> in the Operating Partnership and has been issued a separate class of limited partnership units (the “Special Units”), which are collectively recorded as non-controlling interests on the consolidated balance sheets as of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December 31, 2013</font><font style="font-family:inherit;font-size:10pt;">. As the Company accepts subscriptions for shares, it contributes substantially all of the net proceeds from its continuous, public offering to the Operating Partnership as a capital contribution. As of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2014</font><font style="font-family:inherit;font-size:10pt;">, the Company’s limited partnership interest in the Operating Partnership was </font><font style="font-family:inherit;font-size:10pt;">99.9%</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s charter authorizes the issuance of up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">400,000,000</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock with a par value of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.01</font><font style="font-family:inherit;font-size:10pt;"> per share and up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">50,000,000</font><font style="font-family:inherit;font-size:10pt;"> shares of preferred stock with a par value of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.01</font><font style="font-family:inherit;font-size:10pt;"> per share. The board of directors of the Company is authorized to amend its charter, without the approval of the stockholders, to increase the aggregate number of authorized shares of capital stock or the number of shares of any class or series that the Company has authority to issue.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 12, 2010, as part of its formation, the Company issued </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">22,223</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock to the Sponsor for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> (the “Initial Shares”). On August 7, 2012, the Company’s registration statement on Form S-11 with the SEC to offer a maximum of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">110,526,315</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock, excluding the Initial Shares, in a continuous, public offering, of which up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">100,000,000</font><font style="font-family:inherit;font-size:10pt;"> shares are being offered pursuant to the primary offering (the “Primary Offering”) and up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">10,526,315</font><font style="font-family:inherit;font-size:10pt;"> shares are being offered pursuant to the distribution reinvestment plan (the “DRP”), which are herein collectively referred to as the Offering, was declared effective. At that time, the Company retained NorthStar Realty Securities, LLC (the “Dealer Manager”), a subsidiary of the Sponsor that will be a subsidiary of NSAM following the completion of the spin-off, to serve as the dealer manager for the Primary Offering. The Dealer Manager is responsible for marketing the shares being offered pursuant to the Primary Offering. The board of directors of the Company has the right to reallocate shares between the Primary Offering and the DRP.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 11, 2013, the Company commenced operations by satisfying the minimum offering requirement in its Primary Offering as a result of the Sponsor purchasing an additional </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">222,223</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;">. In April 2014, the Company’s board of directors determined to extend the Offering for one year to August 7, 2015. From inception through </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">May 13, 2014</font><font style="font-family:inherit;font-size:10pt;">, the Company raised total gross proceeds of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$265.9 million</font><font style="font-family:inherit;font-size:10pt;">, excluding the proceeds from the Initial Shares.</font></div></div>
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	129215760	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	2045007	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	0	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-96246430	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2965019	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	0	USD
CY2013Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-5	USD
CY2014Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-27881	USD
CY2013Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6083	USD
CY2014Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3409665	USD
CY2014Q1	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	917109	USD
CY2013	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	210077	USD
CY2013Q4	us-gaap	Notes Payable NotesPayable	18282328	USD
CY2014Q1	us-gaap	Number Of Units In Real Estate Property NumberOfUnitsInRealEstateProperty	846	unit
CY2014Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	1031792	USD
CY2014Q1	us-gaap	Other Assets OtherAssets	340825	USD
CY2013Q4	us-gaap	Other Assets OtherAssets	1124698	USD
CY2013Q1	us-gaap	Other Expenses OtherExpenses	6088	USD
CY2014Q1	us-gaap	Other Expenses OtherExpenses	3846498	USD
CY2013Q4	us-gaap	Other Liabilities OtherLiabilities	263750	USD
CY2014Q1	us-gaap	Other Liabilities OtherLiabilities	134279	USD
CY2013Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
CY2014Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1045925	USD
CY2013Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	USD
CY2014Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2024634	USD
CY2013Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2014Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1653901	USD
CY2013Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	0	USD
CY2014Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	83054715	USD
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2014Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2014Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	89585071	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	45000	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	0	USD
CY2014Q1	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	1099149	USD
CY2014Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	917109	USD
CY2013Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2014Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	41500000	USD
CY2013Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2013Q1	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities	0	USD
CY2014Q1	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities	-160000	USD
CY2014Q1	us-gaap	Profit Loss ProfitLoss	-3437546	USD
CY2013Q1	us-gaap	Profit Loss ProfitLoss	-6088	USD
CY2013	us-gaap	Profit Loss ProfitLoss	-2569904	USD
CY2014Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	829403	USD
CY2014Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	137154718	USD
CY2014Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	136325315	USD
CY2013Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	53968827	USD
CY2014Q1	us-gaap	Real Estate Revenue Net RealEstateRevenueNet	1031792	USD
CY2013Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2014Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	47034	USD
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1883411	USD
CY2014Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	3970252	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3872150	USD
CY2014Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9843897	USD
CY2013Q1	us-gaap	Revenues Revenues	0	USD
CY2014Q1	us-gaap	Revenues Revenues	4447298	USD
CY2013	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	337200	USD
CY2014Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	1099149	USD
CY2014Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	89401502	USD
CY2013	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	96596036	USD
CY2013	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	32367	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	93495897	USD
CY2014Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	178926685	USD
CY2012Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	202007	USD
CY2013Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	93495897	USD
CY2014Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	12656	USD
CY2014Q1	us-gaap	Stockholders Equity StockholdersEquity	177835020	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	93293460	USD
CY2014Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Estimates</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that could affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates and assumptions.</font></div></div>
CY2014Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	15550724	shares
CY2013Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	151656	shares
CY2013Q1	nshi	Accrued Cost Of Capital AccruedCostOfCapital	29213	USD
CY2014Q1	nshi	Accrued Cost Of Capital AccruedCostOfCapital	713828	USD
CY2014Q1	nshi	Acquisition Feeand Expense Cap AcquisitionFeeandExpenseCap	0.06
CY2014Q1	nshi	Annual Distribution Rate AnnualDistributionRate	0.0675
CY2014Q1	nshi	Business Combination Recognized Identifiable Assets Acquired Equityand Liabilities Assumed BusinessCombinationRecognizedIdentifiableAssetsAcquiredEquityandLiabilitiesAssumed	141177832	USD
CY2014Q1	nshi	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Equity BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEquity	79800952	USD
CY2014Q1	nshi	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Equity Controlling Interest BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEquityControllingInterest	78677068	USD
CY2014Q1	nshi	Common Stock Dividend Declared Based On Daily Amount Per Share CommonStockDividendDeclaredBasedOnDailyAmountPerShare	0.00184932
CY2014Q1	nshi	Gross Subscriptions Receivable GrossSubscriptionsReceivable	1360002	USD
CY2013Q1	nshi	Gross Subscriptions Receivable GrossSubscriptionsReceivable	0	USD
CY2014Q1	nshi	Impaired Real Estate Debt Investments ImpairedRealEstateDebtInvestments	0	USD
CY2013Q1	nshi	Increase Decreasein Escrow Payable IncreaseDecreaseinEscrowPayable	0	USD
CY2014Q1	nshi	Increase Decreasein Escrow Payable IncreaseDecreaseinEscrowPayable	857487	USD
CY2013Q4	nshi	Lineof Credit Facility Durationof Extension Option LineofCreditFacilityDurationofExtensionOption	P1Y
CY2014Q1	nshi	Mortgage Loans On Real Estate Current Yield Percentage MortgageLoansOnRealEstateCurrentYieldPercentage	0.082
CY2013Q4	nshi	Mortgage Loans On Real Estate Current Yield Percentage MortgageLoansOnRealEstateCurrentYieldPercentage	0.081
CY2014Q1	nshi	Mortgage Loans On Real Estate Weighted Average Period Of Contractual Maturity Including Extensions MortgageLoansOnRealEstateWeightedAveragePeriodOfContractualMaturityIncludingExtensions	P4Y5M
CY2014Q1	nshi	Number Of Days Past Due For Suspension Of Income Recognition NumberOfDaysPastDueForSuspensionOfIncomeRecognition	P90D
CY2014Q1	nshi	Numberof Days Past Contractual Debt Service Payments Loan Categorizedasa Weaker Credit Quality Debt Investment NumberofDaysPastContractualDebtServicePaymentsLoanCategorizedasaWeakerCreditQualityDebtInvestment	P90D
CY2014Q1	nshi	Numberof Real Estate Equity Investments NumberofRealEstateEquityInvestments	9	property
CY2013Q1	nshi	Payments For Acquisition Of Real Estate Debt Investments PaymentsForAcquisitionOfRealEstateDebtInvestments	0	USD
CY2014Q1	nshi	Payments For Acquisition Of Real Estate Debt Investments PaymentsForAcquisitionOfRealEstateDebtInvestments	14637000	USD
CY2014Q1	nshi	Percentof Intereset Income Contributedby Investment PercentofInteresetIncomeContributedbyInvestment	0.10
CY2014Q1	nshi	Percentof Real Estate Equity Investmentby Property Type PercentofRealEstateEquityInvestmentbyPropertyType	1
CY2014Q1	nshi	Proceeds From Issuance Of Common Stock Related Party ProceedsFromIssuanceOfCommonStockRelatedParty	0	USD
CY2013Q1	nshi	Proceeds From Issuance Of Common Stock Related Party ProceedsFromIssuanceOfCommonStockRelatedParty	2000007	USD
CY2014Q1	nshi	Real Estate Equity Investment Property Net RealEstateEquityInvestmentPropertyNet	141177832	USD
CY2014Q1	nshi	Share Repurchase Program Holding Period Of Shares Required For Repurchase ShareRepurchaseProgramHoldingPeriodOfSharesRequiredForRepurchase	P1Y
CY2014Q1	dei	Amendment Flag AmendmentFlag	false
CY2014Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2014Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2014Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014Q1	dei	Document Period End Date DocumentPeriodEndDate	2014-03-31
CY2014Q1	dei	Document Type DocumentType	10-Q
CY2014Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001503707
CY2014Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	26715387	shares
CY2014Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2014Q1	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2014Q1	dei	Entity Number Of Employees EntityNumberOfEmployees	0	employee
CY2014Q1	dei	Entity Registrant Name EntityRegistrantName	NorthStar Healthcare Income, Inc.

Files In Submission

Name	View Source	Status
0001503707-14-000040-index-headers.html	Edgar Link	pending
0001503707-14-000040-index.html	Edgar Link	pending
0001503707-14-000040.txt	Edgar Link	pending
0001503707-14-000040-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
geotype5814a04.jpg	Edgar Link	pending
nshi-033114x10xq.htm	Edgar Link	pending
nshi-20140331.xml	Edgar Link	completed
nshi-20140331.xsd	Edgar Link	pending
nshi-20140331_cal.xml	Edgar Link	unprocessable
nshi-20140331_def.xml	Edgar Link	unprocessable
nshi-20140331_lab.xml	Edgar Link	unprocessable
nshi-20140331_pre.xml	Edgar Link	unprocessable
nshiexhibit311-033114.htm	Edgar Link	pending
nshiexhibit312-033114.htm	Edgar Link	pending
nshiexhibit321-033114.htm	Edgar Link	pending
nshiexhibit322-033114.htm	Edgar Link	pending
proptype5814a02.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHHS
NorthStar Healthcare Income, Inc. Stock $nhhs

2014 Q2 Form 10-Q Financial Statement

#000150370714000040 Filed on May 15, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHHS NorthStar Healthcare Income, Inc. Stock $nhhs

2014 Q2 Form 10-Q Financial Statement

#000150370714000040 Filed on May 15, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHHS
NorthStar Healthcare Income, Inc. Stock $nhhs